Canada's Provincial and Territorial Routine (and Catch-up) Vaccination Routine Schedule Programs for Infants and Children

This table summarizes the current routine vaccination schedule for infants and children in all provinces and territories across Canada. Changes to this schedule are updated regularly in collaboration with the Canadian Nursing Coalition for Immunization (CNCI) and the Canadian Immunization Committee (CIC);  Schedules for each province or territory are available. Additional information is available on  Canada.ca\vaccines. (last update: August 2018)

2018

Alternative Formats

Vaccination Schedules
Vaccines Provinces & Territories
Abbreviations Descriptions BC AB SK MB ON QCFootnote 6 NB NS PE NL YT NT NU
DTaP-IPV-Hib Diphtheria, Tetanus, acellular Pertussis, Inactivated Polio Virus, Haemophilus Influenzae type B vaccine Age:
18 months		 Age:
18 months		 Age:
2, 4, 6, 18 months		 Age:
2, 4, 6, 18 months		 Age:
2, 4, 6, 18 months		 Age:
6 months		 Age:
2, 4, 6, 18 months		 Age:
2, 4, 6, 18 months		 Age:
18 months		 Age:
2, 4, 6, 18 months		 Age:
18 months		 Age:
2, 4, 6, 18 months		 Age:
2, 4, 6, 18 months
DTaP-HB-IPV-Hib Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Inactivated Polio Virus, Haemophilus Influenzae type B vaccine Age:
2, 4, 6 months		 Age:
2, 4, 6 months		 N/A N/A N/A Age:
2, 4, 18 months		 N/A N/A Age:
2, 4, 6 months		 N/A Age:
2, 4, 6 months		 N/A N/A
Tdap-IPV Tetanus, diphtheria (reduced toxoid), acellular pertussis (reduced toxoid), Inactivated Polio Virus vaccine Age:
4-6 years		 Age:
4-6 years		 Age:
4-6 years		 Age:
4-6 years		 Age:
4-6 years		 Age:
4-6 years		 Age:
4 years		 Age:
4-6 years		 Age:
4-5 years		 Age:
4-6 years		 Age:
4-6 years		 Age:
4-6 yearsFootnote 7		 Age:
4-6 years
Tdap Tetanus, diphtheria (reduced toxoid), acellular pertussis (reduced toxoid) vaccine Grade: 9 Grade: 9 Grade: 8 Age:
13-15 years		 Age:
14-16 years		 Grade: Secondary III Grade: 7 Grade: 7 Grade: 9 Grade: 9 Grade: 9 Grade: 7 Grade: 6
HA Hepatitis A Vaccine N/A N/A N/A N/A N/A

Grade: 4

 N/A N/A N/A N/A N/A N/A N/A
HB Hepatitis B vaccine HB is provided
in a 3-dose combination vaccine
(DTaP-HB-
IPV-Hib) in infancy		 (3-dose)
Grade: 5		 (2-dose)
Grade: 6		 (2-dose), Grade: 6 (2-dose)
Grade: 7		 HB is provided
in a 3-dose combination vaccine
(DTaP-HB-
IPV-Hib) in infancy
Catch-up (2-dose)
Grade: 4Footnote 5		 Age:
At birth, 2, 6 months		 (2-dose)
Grade: 7		 HB is provided
in a 3-dose combination vaccine
(DTaP-HB-
IPV-Hib) in infancy		 (2-dose)
Grade: 6		 HB is provided
in a 3-dose combination vaccine
(DTaP-HB-
IPV-Hib) in infancy		 Age:
At birth, 1, 6 months		 Age:
At birth, 1, 9 months
MMR Measles, Mumps, Rubella vaccine Age:
12 months		 N/A N/A N/A Age:
12 months		 Age:
12 months		 N/A N/A N/A N/A Age:
12 months		 N/A N/A
Var Varicella vaccine Age:
12 months		 N/A Catch-up (2nd dose) Grade: 6 N/A Age:
15 months		 Age: 4-6 yrs Catch-up (2nd dose) Grade: 9 N/A N/A N/A Age:
12 months		 N/A Catch-up
Grade: 6
MMR-V Measles, Mumps, Rubella, Varicella vaccine 2nd dose
Age:
4-6 years		 Age:
12 months, 4-6 years		 Age:
12, 18 months		 Age:
12 months, 4-6 years		 2nd dose
Age:
4-6 years		 Age:
18 months		 Age:
12, 18 months		 Age:
12, 18 months-6 yrs		 Age:
12, 18 months		 Age:
12, 18 months		 2nd dose
Age:
4-6 years		 Age:
12, 36 months		 Age:
12, 18 months
Men-C-C Meningococcal conjugate (Strain C) vaccine Age:
2, 12 months		 Age:
4, 12 months		 Age:
12 months		 Age:
12 monthsFootnote 4		 Age:
12 months		 Age:
12 months,
3rd year of high school		 Age:
12 months		 Age:
12 months		 Age:
12 months		 Age:
12 months		 Age:
2, 12 months
 Age:
2, 12 months		 Age:
12 months
Men-C-ACYW-135 Meningococcal conjugate (Strains A, C, Y, W135) vaccine Grade: 9 Grade: 9 Grade: 6 N/A Grade: 7 N/A Grade: 9 Grade: 7 Grade: 9 Grade: 4 Grade 9 Grade: 12
Footnote 1		 Grade 9
Pneu-C-13 Pneumococcal conjugate (13-valent) vaccine Age:
2, 4, 12 months		 Age:
2, 4, 12 months		 Age:
2, 4, 12 months		 Age:
2, 4, 12 months		 Age:
2, 4, 12 months		 N/A Age:
2, 4, 12 months		 Age:
2, 4, 12 months		 Age:
2, 4, 6 if high risk, 12 months		 Age: 2, 4, 6 if high risk12 mos Age:
2, 4, 12 months		 Age:
2, 4, 6, 18 months		 Age:
2, 4, 6, 18 months
Pneu-C-10 Pneumococcal conjugate (10-valent) vaccine N/A N/A N/A N/A N/A Age:
2, 4, 12 months Footnote 8		 N/A N/A N/A N/A N/A N/A N/A
Rota Rotavirus vaccine Age:
2, 4, 6 months		 Age:
2, 4, 6 months		 Age:
2, 4, 6 months		 Age:
2, 4, 6 months		 Age:
2, 4, 6 months		 Age:
2, 4 months		 Age:
2, 4, 6 months		 N/A Age:
2, 4, 6 months		 Age:
2, 4, 6 months		 Age:
2, 4, 6 months		 Age:
2, 4, 6 months		 Age:
2, 4, 6 months
HPV Human Papillomavirus vaccine (2-dose)
Grade: 6
 (2-dose)
Grade: 6

Catch-up
(3-dose) 2014 to 2018 Grade: 9
Footnote 3		 (2-dose) Grade: 6 (2-dose) Grade: 6
Catch-up
(2-dose)
Grade: 8,9Footnote 3		 (2-dose) Grade: 7
Catch-up (2 or 3 -dose) Grades 8 to 12Footnote 2


(2-dose)
Grade: 4

 (2-dose)
Grade 7		 (2-dose) Grade: 7 (2-dose)
Grade: 6		 (2-dose) Grade: 6 (2-dose) Grade: 6 (9-14 years: 2-dose 15 years +: 3-dose)
Grade: 4-6		 (2-dose)
Grade: 6
Footnote 1

If attending post-secondary school out-of territory.

Return to footnote 1 referrer

Footnote 2

Females only

Return to first footnote 2 referrer

Footnote 3

Males only

Return to first footnote 3 referrer

Footnote 4

Starting as early as September 2019, Manitoba's Meningococcal School-Based Immunization Program will be offered at a later grade: no child will miss the opportunity to be vaccinated.

Return to footnote 4 referrer

Footnote 5

Students are provided with a combination vaccine that protects against hepatitis A and B.

Return to footnote 5 referrer

Footnote 6

A catch-up program in the 3rd year of high-school evaluates student’s vaccination history. Students will be provided any missed vaccination to protect against the following diseases: diphtheria, pertussis, tetanus, polio, measles, mumps, rubella, varicella, meningoccal serogroup C infections, hepattis A and B, and human papilloma virus.

Return to footnote 6 referrer

Footnote 7

DTaP-IPV-Hib may be substituted for DTaP-IPV in times of shortage

Return to footnote 7 referrer

Footnote 8

An expert committee in Quebec has recommended the use of pneumo-C-10 for children based on the pneumococcal bacteria currently circulating in Quebec which can cause a serious infection in young children.

Return to footnote 8 referrer
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: